CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $347,711,405
- in 75 filings, $346.9M under 10b5-1 plans
Net −$347,711,405. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −280 | $472.43 | $132K | 333,663 |
| 2026-09-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −600 | $473.28 | $284K | 333,063 |
| 2026-09-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −680 | $474.46 | $323K | 332,383 |
| 2026-09-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −80 | $475.28 | $38K | 332,303 |
| 2026-09-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −160 | $476.68 | $76K | 332,143 |
| 2026-09-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −200 | $477.45 | $95K | 331,943 |
| 2026-09-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −601 | $479.06 | $288K | 331,342 |
| 2026-09-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,013 | $480.18 | $486K | 330,329 |
| 2026-09-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,354 | $481.20 | $652K | 328,975 |
| 2026-09-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −693 | $482.11 | $334K | 328,282 |
| 2026-09-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,539 | $483.20 | $744K | 326,743 |
| 2026-09-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −825 | $484.47 | $400K | 325,918 |
| 2026-09-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,315 | $485.45 | $638K | 324,603 |
| 2026-09-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −160 | $486.01 | $78K | 324,443 |
| 2026-09-28 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 347,410 | ||
| 2026-09-25 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-09-25 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −40 | $470.56 | $19K | 333,903 |
| 2026-09-25 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −200 | $471.84 | $94K | 333,703 |
| 2026-09-25 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −800 | $472.89 | $378K | 332,903 |
| 2026-09-25 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −543 | $474.15 | $257K | 332,360 |
Page 31 of 121 · 2,404 trades